Its flagship drug, Omburtamab, was designed to target central nervous system and leptomeningeal metastases in pediatric neuroblastoma patients. Y-mAbs aimed to commercialize Omburtamab, promoting it ...

The mother of a young boy has revealed how 'unusual' bruising on her son's eyelid led to a life-changing diagnosis.